Nutritional Therapy Interventions in Heart Failure
Effects of 12 Weeks of Nutritional Therapy Interventions in Heart Failure
1 other identifier
interventional
63
1 country
1
Brief Summary
The investigators will examine the effects of 12-weeks of nutritional interventions in older participants who have a symptom of mild to moderate heart failure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 31, 2018
CompletedFirst Posted
Study publicly available on registry
February 6, 2018
CompletedStudy Start
First participant enrolled
February 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 27, 2019
CompletedResults Posted
Study results publicly available
August 19, 2020
CompletedJuly 12, 2021
July 1, 2021
1.4 years
January 31, 2018
July 8, 2020
July 8, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Functional Test
Measuring 6 minutes walking before and after the intervention. \*\*\*The results below are the actual increases of walking distance (mean and SD) changes from baseline to end of 12-week intervention.
Change from baseline to 12 weeks
Study Arms (2)
9g of EAA mixture supplement
EXPERIMENTALTwice a day for 12 consecutive weeks.
9g of placebo (whey protein)
EXPERIMENTALTwice a day for 12 consecutive weeks.
Interventions
Dietary supplement intervention for 12-weeks
Dietary supplement intervention for 12-weeks
Eligibility Criteria
You may qualify if:
- BMI between 18 and 40 kg/m2
- Any ethnicity
- Presence of mild-to-moderate heart failure (NYHA II or III symptomatology) as evidenced by prescribed diuretics or reported shortness of breath upon exertion
You may not qualify if:
- Allergic to milk or soy products
- Hemoglobin \<10 g/dL
- Estimated Glomerular Filtration Rate (eGFR) \< 30
- Inability to perform strength and/or functional assessments
- Myocardial infarction in the past 6 months
- Unstable angina
- Moderate-severe heart valve disease
- Atrial fibrillation or other significant (as determined by PI) arrhythmias
- Infiltrative, restrictive or hypertrophic cardiomyopathy
- Dementia -determined by a SLUMS score of \<20
- Currently having inflammatory bowel disease
- Received chemotherapy or radiation therapy within the past 12 months
- Currently undergoing tube feeding
- Currently receiving palliative care for end-of-life circumstance
- Unwilling to refrain from using non-study protein/amino acid supplements during their participation in this study
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Related Publications (2)
Azhar G, Verma A, Zhang X, Pangle A, Patyal P, Zhang W, Che Y, Coker K, Wolfe RR, Wei JY. Differential plasma protein expression after ingestion of essential amino acid-based dietary supplement verses whey protein in low physical functioning older adults. Geroscience. 2023 Jun;45(3):1729-1743. doi: 10.1007/s11357-023-00725-5. Epub 2023 Feb 1.
PMID: 36720768DERIVEDAzhar G, Wei JY, Schutzler SE, Coker K, Gibson RV, Kirby MF, Ferrando AA, Wolfe RR. Daily Consumption of a Specially Formulated Essential Amino Acid-Based Dietary Supplement Improves Physical Performance in Older Adults With Low Physical Functioning. J Gerontol A Biol Sci Med Sci. 2021 Jun 14;76(7):1184-1191. doi: 10.1093/gerona/glab019.
PMID: 33475727DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Scott Schutzler, R.N.
- Organization
- University of Arkansas for Medical Sciences
Study Officials
- PRINCIPAL INVESTIGATOR
Gohar Azhar, M.D
University of Arkansas
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 31, 2018
First Posted
February 6, 2018
Study Start
February 15, 2018
Primary Completion
June 27, 2019
Study Completion
June 27, 2019
Last Updated
July 12, 2021
Results First Posted
August 19, 2020
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share